Assess disease severity in mucopolysaccharidosis type I (Hurler, Hurler-Scheie, Scheie phenotypes) across cognitive, skeletal, cardiac, airway, and corneal domains to guide haematopoietic stem cell transplantation and enzyme replacement timing.
Assess disease severity in mucopolysaccharidosis type I (Hurler, Hurler-Scheie, Scheie phenotypes) across cognitive, skeletal, cardiac, airway, and corneal domains to guide haematopoietic stem cell transplantation and enzyme replacement timing
Each component has a specific meaning:
Note: Interpret the mps i severity result against the thresholds and context described above.
Enter the cognitive, skeletal, cardiac, airway, corneal domains for the scenario you are assessing. Assess disease severity in mucopolysaccharidosis type I (Hurler, Hurler-Scheie, Scheie phenotypes) across cognitive, skeletal, cardiac, airway, and corneal domains to guide haematopoietic stem cell transplantation and enzyme replacement timing. Use the mps i severity result to inform your calculation.